Nuclear magnetic resonance spectrometric assay of beta-lactamase.

Antimicrobial Agents and Chemotherapy
M KonoY Shiomi

Abstract

Beta-Lactam antibiotics and the crude enzyme were mixed in deuterium oxide and placed in a nuclear magnetic resonance tube. The change of the nuclear magnetic resonance spectrum during the enzymatic reaction was then analyzed to determine beta-lactamase activity. By using beta-lactam antibiotics such as penicillins, cephalosporins, and cephamycins as substrates, a comparison of the beta-lactamase activities was made between the nuclear magnetic resonance spectrometric assay and the iodometric assay. There was a close correlation between these two methods.

References

Jun 1, 1978·Antimicrobial Agents and Chemotherapy·T NishiuraM Kono
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Jun 1, 1974·The Biochemical Journal·S G Waley
Jan 1, 1973·Advances in Microbial Physiology·M H Richmond, R B Sykes
Apr 1, 1968·Journal of Bacteriology·M G Sargent
Nov 27, 1954·Nature·C J PERRET
May 1, 1962·The Biochemical Journal·R P NOVICK

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.